akhil911
Many of these gene flaws - there are plenty of them, with names like BCR-ABL - are relative newcomers to
medical terminology, as are a majority of the new anti-tumor drugs, still in early testing, that are aimed at them.
A. medical terminology, as are a majority of the new anti-tumor drugs, still in early testing, that are aimed at them.
The comparison word 'as' is the right usage, that are usage is delivering the right meaning therefore our answer
B. medical terminology like a majority of the new anti-tumor drugs that are still in early testing, and aimed at them.
like isn't the right usage for comparison, in addition and is unnecessary therefore out
C. medical terminology, as are a majority of the new anti-tumor drugs that are still in early testing, aimed at them.
The comparison is fine however aimed at them isn't conveying the right meaning therefore out
D. medical terminology like a majority of the new anti-tumor drugs, still in early testing, that are aimed at them.
Similar reasoning as B
E. medical terminology, as are a majority of the new anti-tumor drugs, still in early testing, and aimed at them.
and aimed at them isn't delivering the right meaning therefore out
THerefore IMO A